Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Outcome of Patients with Multiple Myeloma (MM) After 1st Relapse Following Front-Line Treatment with Autologous Stem Cell Transplantation (ASCT): Impact of Early Reduced Intensity Allogeneic Transplantation (RICALLO)

Reza Tabrizi, MD, Stephane Vigouroux, MD, Gerald Marit, MD, PhD, Arnaud Pigneux, MD, PhD, Cyril Melot, Thibaut Leguay, MD, Krimo Bouabdallah, MD, Marie-Sarah Dilhuydy, MD, Anna Schmitt, Noel Milpied, MD

Blood (2011) 118 (21): 4533.

https://doi.org/10.1182/blood.V118.21.4533.4533

Published: 2011

Journal Articles

Yttrium-90-Ibritumomab Tiuxetan (Zevalin) in Combination with a Fludarabine-Based Reduced Conditioning Regimen (RIC) Followed by Allogenic Stem Cell Transplantation for Advanced/Aggressive Non-Hodgkin's Lymphoma (NHL): A Prospective, Multicentre, Open Phase II Study

Krimo Bouabdallah, MD, Sabine Furst, MD, Reda Bouabdallah, MD, Stephane Vigouroux, MD, Reza Tabrizi, MD, Cyril Melot, Steven Le Gouill, MD, PhD, Nathalie Fegueux, Olivier Tournilhac, MD, PhD, Mohamad Mohty, Didier Blaise, MD, noel-Jean Milpied, MD

Blood (2011) 118 (21): 3027.

https://doi.org/10.1182/blood.V118.21.3027.3027

Published: 2011

Journal Articles

A Phase II Study of Yttrium-90-Ibritumomab Tiuxetan In Combination with a Fludarabine-Based Reduced Intensity Regimen Followed by Allogenic Stem Cell Transplantation In Patients with Relapsed or Chemorefractory CD 20 Positive Non-Hodgkin's Lymphoma.

Krimo Bouabdallah, Sabine Furst, Reda Bouabdallah, Stephane Vigouroux, Reza Tabrizi, Cyril Melot, Steven Le Gouill, Nathalie Fegueux, MD, Mohamad Mohty, Didier Blaise, MD, Noel-Jean Milpied, MD

Blood (2010) 116 (21): 4565.

https://doi.org/10.1182/blood.V116.21.4565.4565

Published: 2010

Journal Articles

Ciclosporine and Metotrexate Reduce the Risk of High Grade Acute Gvhd after Busulfan, Fludarabine and Anti-Thymocyte Globulin conditioning Regimen in Comparison with Cyclosporine Alone

Reza Tabrizi, Stephane Vigouroux, Arnaud Pigneux, Thibaut Leguay, Krimo Bouabdallah, Marie-Sarah Dilhuydy, Carine Foucaud, Pierre-Yves Dumas, Axelle Lascaux, Mohamed Zarrouk, Jean-Michel Boiron, MD, PhD, Fontanet Bijou, Pascal Turlure, Cyril Melot, Gerald Marit, Noel Milpied

Blood (2008) 112 (11): 4331.

https://doi.org/10.1182/blood.V112.11.4331.4331

Published: 2008

Journal Articles

Allogeneic Stem Cell Transplantation with Reduced Intensity Conditionning Regimen (RIC) for Adult Patients with AML: Same Results in Secondary and De Novo AML.

Noel-Jean Milpied, MD, Reza Tabrizi, MD, Thierry Guillaume, MD, Patrice Chevallier, MD, Arnaud Pigneux, MD, Jean Michel Boiron, MD, Philippe Moreau, MD, Beatrice Mahe, MD, Thibaut Leguay, MD, Krimo Bouabdallah, MD, Nadine Morineau, MD, Jacques Delaunay, MD, Cyril Melot, Beatrice Saulquin, Gerald Marit, MD, Jean Luc Harousseau, MD

Blood (2006) 108 (11): 3015.

https://doi.org/10.1182/blood.V108.11.3015.3015

Published: 2006

Journal Articles

Usefulness of Recombinant Human Erythropoietin during Induction-Consolidation Chemotherapy for Chronic Hematological Lymphoid Malignancies: Improving Stem Cell Harvest and Reducing Blood-Product Support for Patients Receiving Autologous Stem-Cell Transplantation.

Fontanet D. Bijou, MD, Reza Tabrizi, MD, Thibaut Legay, MD, Cyril Melot, Krimo Bouabdallah, MD, Arnaud Pigneux, MD, Jean-Michel Boiron, MD, Gerald Marit, MD

Blood (2005) 106 (11): 5293.

https://doi.org/10.1182/blood.V106.11.5293.5293

Published: 2005

Journal Articles

Dendritic Cells Recovery and Chimerism after Reduced Intensity Hematopoietic Stem Cell Transplantation.

Reza Tabrizi, MD, Francis Belloc, PhD, Xavier Lafarge, Virginie Perreau, Krimo Bouabdallah, MD, Gerald Marit, MD, Fontanet Bijou, MD, Thibaut Leguay, MD, Francis Lacombe, Arnaud Pigneux, MD, Cyril Melot, François Comeau, Jean-Michel Boiron, MD, PhD

Blood (2005) 106 (11): 5341.

https://doi.org/10.1182/blood.V106.11.5341.5341

Published: 2005

NARROW

Outcome of Patients with Multiple Myeloma (MM) After 1st Relapse Following Front-Line Treatment with Autologous Stem Cell Transplantation (ASCT): Impact of Early Reduced Intensity Allogeneic Transplantation (RICALLO)

Yttrium-90-Ibritumomab Tiuxetan (Zevalin) in Combination with a Fludarabine-Based Reduced Conditioning Regimen (RIC) Followed by Allogenic Stem Cell Transplantation for Advanced/Aggressive Non-Hodgkin's Lymphoma (NHL): A Prospective, Multicentre, Open Phase II Study

A Phase II Study of Yttrium-90-Ibritumomab Tiuxetan In Combination with a Fludarabine-Based Reduced Intensity Regimen Followed by Allogenic Stem Cell Transplantation In Patients with Relapsed or Chemorefractory CD 20 Positive Non-Hodgkin's Lymphoma.

Ciclosporine and Metotrexate Reduce the Risk of High Grade Acute Gvhd after Busulfan, Fludarabine and Anti-Thymocyte Globulin conditioning Regimen in Comparison with Cyclosporine Alone

Allogeneic Stem Cell Transplantation with Reduced Intensity Conditionning Regimen (RIC) for Adult Patients with AML: Same Results in Secondary and De Novo AML.

Usefulness of Recombinant Human Erythropoietin during Induction-Consolidation Chemotherapy for Chronic Hematological Lymphoid Malignancies: Improving Stem Cell Harvest and Reducing Blood-Product Support for Patients Receiving Autologous Stem-Cell Transplantation.

Dendritic Cells Recovery and Chimerism after Reduced Intensity Hematopoietic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Outcome of Patients with Multiple Myeloma (MM) After 1st Relapse Following Front-Line Treatment with Autologous Stem Cell Transplantation (ASCT): Impact of Early Reduced Intensity Allogeneic Transplantation (RICALLO)

Yttrium-90-Ibritumomab Tiuxetan (Zevalin) in Combination with a Fludarabine-Based Reduced Conditioning Regimen (RIC) Followed by Allogenic Stem Cell Transplantation for Advanced/Aggressive Non-Hodgkin's Lymphoma (NHL): A Prospective, Multicentre, Open Phase II Study

A Phase II Study of Yttrium-90-Ibritumomab Tiuxetan In Combination with a Fludarabine-Based Reduced Intensity Regimen Followed by Allogenic Stem Cell Transplantation In Patients with Relapsed or Chemorefractory CD 20 Positive Non-Hodgkin's Lymphoma.

Ciclosporine and Metotrexate Reduce the Risk of High Grade Acute Gvhd after Busulfan, Fludarabine and Anti-Thymocyte Globulin conditioning Regimen in Comparison with Cyclosporine Alone

Allogeneic Stem Cell Transplantation with Reduced Intensity Conditionning Regimen (RIC) for Adult Patients with AML: Same Results in Secondary and De Novo AML.

Usefulness of Recombinant Human Erythropoietin during Induction-Consolidation Chemotherapy for Chronic Hematological Lymphoid Malignancies: Improving Stem Cell Harvest and Reducing Blood-Product Support for Patients Receiving Autologous Stem-Cell Transplantation.

Dendritic Cells Recovery and Chimerism after Reduced Intensity Hematopoietic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only